Not checked for notices yet.
Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
Melissa eBartel, David eSchaffer, Hildegard eBüning and 1 more
Frontiers in Microbiology · 2011
Cited by papers we hold 2
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes · 2019No notice
- Humoral Immune Response to AAV · 2013No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.